510(k) K230236
K230236 is an FDA 510(k) premarket notification submitted by Quidel Corporation for the device "Lyra Influenza A+B Assay". The FDA issued a decision of Substantially Equivalent on Mar 3, 2023. The device falls under product code OZE (Influenza A And Influenza B Multiplex Nucleic Acid Assay), a Class II device regulated under 21 CFR 866.3980. Quidel Corporation has 36 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Mar 3, 2023
- Date Received
- Jan 30, 2023
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Influenza A And Influenza B Multiplex Nucleic Acid Assay
- Device Class
- Class II
- Regulation Number
- 866.3980
- Review Panel
- MI
- Submission Type
- 510(k)
An Influenza A and Influenza B multiplex nucleic acid assay is a multiplex in vitro diagnostic test for the simultaneous qualitative detection and discrimination of influenza A and influenza B nucleic acids isolated and purified from human respiratory specimens obtained from individuals exhibiting signs and symptoms of respiratory tract infections or viral culture. The detection and discrimination of influenza A and B nucleic acids from symptomatic patients aid in the diagnosis of human respiratory tract influenza viral infections if used in conjunction with other clinical and laboratory findings.
Need the full FDA record for Quidel Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.